Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders.
about
Brazilin isolated from Caesalpinia sappan L. acts as a novel collagen receptor agonist in human plateletsStructure of an agonist-bound human A2A adenosine receptorToward selective drug development for the human 5-hydroxytryptamine 1E receptor: a comparison of 5-hydroxytryptamine 1E and 1F receptor structure-affinity relationshipsThe GABA B receptor agonist CGP44532 and the positive modulator GS39783 reverse some behavioural changes related to positive syndromes of psychosis in mice.Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disordersASD: a comprehensive database of allosteric proteins and modulatorsDiscovery of (R)-(2-fluoro-4-((-4-methoxyphenyl)ethynyl)phenyl) (3-hydroxypiperidin-1-yl)methanone (ML337), an mGlu3 selective and CNS penetrant negative allosteric modulator (NAM)Ligand binding assays at equilibrium: validation and interpretationChemical lead optimization of a pan Gq mAChR M1, M3, M5 positive allosteric modulator (PAM) lead. Part II: development of a potent and highly selective M1 PAMAllostery at G protein-coupled receptor homo- and heteromers: uncharted pharmacological landscapesSynthesis and evaluation of a series of heterobiarylamides that are centrally penetrant metabotropic glutamate receptor 4 (mGluR4) positive allosteric modulators (PAMs)Norbin is an endogenous regulator of metabotropic glutamate receptor 5 signalingA selective allosteric potentiator of the M1 muscarinic acetylcholine receptor increases activity of medial prefrontal cortical neurons and restores impairments in reversal learningDiscovery and characterization of novel allosteric potentiators of M1 muscarinic receptors reveals multiple modes of activity.Kappa-opioid ligands in the study and treatment of mood disordersRevealing Atomic-Level Mechanisms of Protein Allostery with Molecular Dynamics SimulationsAllosteric Modulation of Chemoattractant ReceptorsNeurobiological Insights from mGlu Receptor Allosteric Modulation.The role of serotonin 5-HT2A receptors in memory and cognitionDiscovery and Development of Small Molecule Allosteric Modulators of Glycoprotein Hormone ReceptorsDirect and Propagated Effects of Small Molecules on Protein-Protein Interaction NetworksFine-tuning multiprotein complexes using small moleculesAdvancing Biological Understanding and Therapeutics Discovery with Small-Molecule ProbesPositive allosteric modulators of metabotropic glutamate 2 receptors in schizophrenia treatmentDiversity and modularity of G protein-coupled receptor structuresRegulation of G protein-coupled receptors by allosteric ligandsNeuroprotective and symptomatic effects of targeting group III mGlu receptors in neurodegenerative diseaseComputational methods in drug discoveryExploring the role of receptor flexibility in structure-based drug discoveryDrugs for allosteric sites on receptorsG-protein-coupled receptors targeting: the allosteric approachPositive allosteric modulators of the μ-opioid receptor: a novel approach for future pain medicationsLigand-specific regulation of the extracellular surface of a G-protein-coupled receptorInhibitory Mechanism of an Allosteric Antibody Targeting the Glucagon ReceptorNovel Allosteric Modulators of G Protein-coupled ReceptorsDiscovery of the first highly M5-preferring muscarinic acetylcholine receptor ligand, an M5 positive allosteric modulator derived from a series of 5-trifluoromethoxy N-benzyl isatinsCharacterization of an mGluR2/3 negative allosteric modulator in rodent models of depressionSweet taste receptor gene variation and aspartame taste in primates and other speciesQuantifying Correlations Between Allosteric Sites in Thermodynamic EnsemblesDrosophila photoreceptor cells exploited for the production of eukaryotic membrane proteins: receptors, transporters and channels
P2860
Q21284423-D46921B7-A095-40A3-8996-B19FC924B6A8Q24296388-23286F0A-E58E-472E-A240-117987C0705FQ24297642-1A630BB6-58E8-44CD-8D05-642B3D78F211Q24596842-D3D3045D-5D4E-461D-B077-B80F8FA5FAC9Q24605472-03E58DEE-0E4B-42A2-973A-0F7616F9CF1DQ24616070-32A633B9-E57B-41EF-97F4-7167A5835D1DQ24625985-82EEEF00-ACA8-4E96-BED8-6EF13D18D39AQ24629851-86262CEF-E58A-446A-9002-C95848B602D3Q24631627-7AEFB158-CF81-4314-A455-CB5161C7F125Q24633877-97F3B46A-A59C-4691-9437-E66614900894Q24650602-FAF5EACC-890C-4D60-B3F8-E6B99FF4EF1AQ24655546-CEE875FF-22F8-4487-A0EC-D90928AB6AE9Q24657785-81EF1904-2811-4834-A670-52B60F6F4E71Q24657902-FC47198E-0DE5-47FA-B510-C2245E990DE3Q24657982-5707523D-75D6-405B-9A5C-978776CD69A7Q26747130-EA8245CF-189F-46C0-8BB5-D7856354CBBFQ26747395-6FBE6576-C17C-4E1F-ADDA-9ABB5077CBF9Q26773431-9AFF5771-99F9-4988-B3A4-B31CA6D89B37Q26779278-D963C863-E4A3-4735-9024-2AB561DCBA85Q26781438-6B5A3E57-EB40-4E11-81A9-AD501901CD05Q26784027-ADAF550C-31F0-4435-85BD-3AC08815DDB2Q26822675-D7140251-BE28-4284-AE98-E3A279AC242CQ26829985-48C73048-23DD-4D1A-8EC2-9C0A9FA0363FQ26852047-7AC03B61-077B-4ADF-8BAF-9BE4B19FF24FQ26852976-6D93D0EF-249F-4497-9EDA-FEFE23F4E5D8Q26864384-EA6D8667-2E9E-4E4C-9DCC-4672391FE6EDQ26995351-8943481C-EE38-4AA1-9DB5-98BC084E0F62Q26997089-5947694B-315C-4DC4-B44A-70B7238FC801Q27001129-0066636A-85EF-483F-A4C5-FE596F4DE9D6Q27006721-4E6CFEA1-E939-4C41-9195-37FF45C4255AQ27023311-2C6C8CA6-085F-49F3-A7FB-E7CE21227DB0Q27027736-2FBECF3F-A1A1-4D94-9D56-779CA96C1CF6Q27646733-63697C1D-FE9B-4A05-8C02-38D804D3F7AFQ27680518-B58BF109-E150-45AE-B1CF-1425E9F25ECAQ28081112-6A29C13F-6017-4D96-B316-5E0F10F452B7Q28244789-49CFEEFD-9BB9-4522-B4F2-EFF0B0F32F18Q28253233-1A512CE7-550C-42BF-A5ED-86D76E780A70Q28388576-CA6B85EF-A04B-4A3F-9807-F5E87E462A53Q28392472-E9FAC0D8-A35F-406D-888E-1298E9334E6AQ28477699-0DF1213D-D042-40D6-97E2-52281F3D31D9
P2860
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders.
@en
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders.
@nl
type
label
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders.
@en
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders.
@nl
prefLabel
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders.
@en
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders.
@nl
P2860
P356
P1476
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders.
@en
P2093
Arthur Christopoulos
P2860
P2888
P356
10.1038/NRD2760
P577
2009-01-01T00:00:00Z
P5875
P6179
1025311434